AMY PEERY: Open Payments
NPI 1518686492 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 39 payments from 10 companies in 2025. Trend: 2023 $937 · 2024 $1,264 · 2025 $1,173
Food & beverage: $1,117Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $497 |
| AstraZeneca Pharmaceuticals LP | 4 | $181 |
| Regeneron Healthcare Solutions, Inc. | 6 | $158 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Amgen Inc. | 3 | $60 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
| Genentech USA, Inc. | 1 | $31 |
| Organon LLC | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, TEZSPIRE, Rhapsido, FASENRA, Xolair, NEFFY.
Industry payments across VA — which companies pay providers there.
